TITLE

A Regimen Containing Rifabutin for the Treatment of Tuberculosis in Patients Intolerant to Rifampin

PUB. DATE
January 2003
SOURCE
Clinical Infectious Diseases;1/1/2003, Vol. 36 Issue 1, p127
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
20507452

 

Related Articles

  • Rifamycin Treatment of Tuberculosis in a Patient Receiving Atenolol: Less Interaction with Rifabutin than with Rifampin. Goldberg, Stefan V.; Hanson, Daniel; Peloquin, Charles A. // Clinical Infectious Diseases;8/15/2003, Vol. 37 Issue 4, p607 

    Comments on an article about the substitution of rifabutin for rifampin in the treatment of patients with tuberculosis who develop intolerable rifampin side effects. Reduction of blood concentrations of many classes of medications that are metabolized in the liver, by rifampin; Illustrative case.

  • Rifampin + rifabutin in HIV patient. M.O.R. // Cortlandt Forum;10/25/96, Vol. 9 Issue 10, p106 

    Comments on the appropriateness of using both rifampin and rifabutin simultaneously for an HIV-positive patient. Aim of treating active tuberculosis and starting prophylactic therapy for Mycobacterium avium-intracellulare; Recommendation of treating tuberculosis first.

  • Evaluation of a Rifapentine-Containing Regimen for Intensive Phase Treatment of Pulmonary TB.  // MD Conference Express;Aug2011, p8 

    The article reports on research which was conducted by Susan E. Dorman of Johns Hopkins University in Baltimore, Maryland in an effort to investigate the effectiveness of using a rifapentine-containing or rifampin-containing regimen in the intensive phase treatment of pulmonary tuberculosis....

  • Relapse and Acquired Rifampin Resistance in HIV-Infected Patients with Tuberculosis Treated with Rifampin- or Rifabutin-Based Regimens in New York City, 1997-2000. Li, Jiehui; Munsiff, Sonal S.; Driver, Cynthia R.; Sackoff, Judith // Clinical Infectious Diseases;7/1/2005, Vol. 41 Issue 1, p83 

    Background. The relationship between rifamycin use and either relapse or treatment failure with acquired rifampin resistance (ARR) among human immunodeficiency virus (HIV)-infected patients with tuberculosis (TB) is not well understood. Methods. We conducted a retrospective cohort study of...

  • Issues in the Treatment of Active Tuberculosis in Human Immunodeficiency Virus--Infected Patients. Schluger, Neil W. // Clinical Infectious Diseases;1/1/1999, Vol. 28 Issue 1, p130 

    Focuses on issues in the treatment of active tuberculosis in HIV infected patients. Efficacy of chemotherapy; Impact of therapy with protease inhibitors on tuberculosis treatment in AIDS patients; Rifabutin therapy.

  • TB regimen revised.  // Patient Care;Oct2003, Vol. 37 Issue 10, p3 

    Reports that the American Thoracic Society and the U.S. Center for Disease Control has revised its recommendations against the use of rifampin and pyrazinamide for treatment of tuberculosis infection in HIV-negative and HIV-infected patients. Diseases associated with rifampin and pyrazinamide...

  • Rifabutin.  // Reactions Weekly;Aug2015, Vol. 1562 Issue 1, p180 

    The article describes cases of hepatitis or blurred vision with uveitis in two patients with tuberculosis during treatment with rifabutin.

  • Treatment of Mycobacterium avium Complex Bactermia in AIDS with a Four-Drug Oral Regimen. Kemper, Carol A.; Tze-Chiang Meng; Nussbaum, Joseph; Chiu, Joseph; Feigal, David F.; Bartok, Angie E.; Leedom, John M.; Tilles, Jeremiah G.; Deresinski, Stanley C.; McCutchan, J. Allen // Annals of Internal Medicine;3/15/92, Vol. 116 Issue 6, p466 

    Studies the treatment of Mycobacterium avium complex bacteremia and AIDS with an entirely oral regimen consisting of the antimycobacterial drugs called rifampin, ethambutol, clofazimine and ciprofloxacin. Symptoms of Mycobacterium avium complex; Reduction in symptoms and bacteremia within two...

  • Uveitis associated with rifabutin therapy.  // MMWR: Morbidity & Mortality Weekly Report;9/9/1994, Vol. 43 Issue 35, p658 

    Reports on the occurrences of uveitis among patients taking the antibiotic rifabutin for prophylaxis of Mycobacterium avium complex (MAC). Dosage and administration of rifabutin; Symptomatology, risk factors and treatment regimen of uveitis; Contact information for reporting cases of uveitis.

  • Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis.  // MMWR: Morbidity & Mortality Weekly Report;2/1/2008, Vol. 57 Issue 4, p98 

    The article presents an updated guidelines for administering pharmacological interactions that can result when HIV patients receive antiretroviral drugs together with rifamycins for treatment of tuberculosis. The new guidelines give additional recommendations on the use rifampin with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics